Tachykinin Receptor 2 (TACR2) Antibody

Este producto es parte de TACR - Tachykinin Receptor
Product Graph
273€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Tachykinin Receptor 2 (TACR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx130253
tested applications
WB, IHC, IF/ICC

Description

Tachykinin Receptor 2 Antibody is a Rabbit Polyclonal against Tachykinin Receptor 2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Tachykinin Receptor 2 (TACR2)
Host
Rabbit
Reactivity
Rat
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
TACR2,Neurokinin B receptor,NKNAR,SKR,TAC2R,neurokinin A receptor,NK-2 receptor,P-E receptor,Substance K receptor,NK2R
Background
Antibody anti-TACR2
Status
RUO

Descripción

TACR2, also known as NK2R, is another member of the tachykinin receptor family, activated by neurokinin B (NKB) and substance P. Like TACR1, TACR2 primarily couples to Gq proteins, which activate phospholipase C (PLC), generating inositol triphosphate (IP3) and increasing intracellular calcium levels. TACR2 is widely expressed in the smooth muscle, particularly in the respiratory and gastrointestinal systems, where it regulates smooth muscle contraction. In the CNS, TACR2 plays a key role in regulating neurogenic inflammation and modulating pain, as well as contributing to the regulation of reproductive function. Dysregulation of TACR2 signaling has been linked to conditions such as asthma, chronic pain syndromes, and reproductive disorders. Selective TACR2 antagonists are being developed to treat asthma, IBS, and other conditions where neurokinin B-mediated effects contribute to disease pathology.

Related Products

EH3843

Human TACR2(Tachykinin Receptor 2) ELISA Kit

Ver Producto
EM1386

Mouse TACR2(Tachykinin Receptor 2) ELISA Kit

Ver Producto
ER1361

Rat TACR2(Tachykinin Receptor 2) ELISA Kit

Ver Producto